|
|
Volumn 3, Issue 1, 2001, Pages 46-55
|
|
Immunobiology and immunotherapy of head and neck cancer.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CANCER VACCINE;
IMMUNOLOGICAL ADJUVANT;
APOPTOSIS;
CANCER STAGING;
COMPARATIVE STUDY;
DENDRITIC CELL;
FEMALE;
FOLLOW UP;
HEAD AND NECK TUMOR;
HUMAN;
IMMUNOLOGICAL TOLERANCE;
IMMUNOLOGY;
IMMUNOTHERAPY;
MALE;
METHODOLOGY;
MORTALITY;
PHYSIOLOGY;
REVIEW;
RISK ASSESSMENT;
SQUAMOUS CELL CARCINOMA;
SURVIVAL;
T LYMPHOCYTE SUBPOPULATION;
TREATMENT OUTCOME;
TUMOR ESCAPE;
ADJUVANTS, IMMUNOLOGIC;
APOPTOSIS;
CANCER VACCINES;
CARCINOMA, SQUAMOUS CELL;
DENDRITIC CELLS;
FEMALE;
FOLLOW-UP STUDIES;
HEAD AND NECK NEOPLASMS;
HUMANS;
IMMUNE TOLERANCE;
IMMUNOTHERAPY;
MALE;
NEOPLASM STAGING;
RISK ASSESSMENT;
SURVIVAL ANALYSIS;
T-LYMPHOCYTE SUBSETS;
TREATMENT OUTCOME;
TUMOR ESCAPE;
|
|
EID: 0002141362
PISSN: 15233790
EISSN: None
Source Type: Journal
DOI: 10.1007/s11912-001-0042-3 Document Type: Review |
|
Times cited : (30)
|
|
References (41)
|
